{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T15:14:48Z","timestamp":1785510888537,"version":"3.56.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1016\/j.ygyno.2016.03.006","type":"journal-article","created":{"date-parts":[[2016,3,10]],"date-time":"2016-03-10T06:12:45Z","timestamp":1457590365000},"page":"312-317","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":94,"title":["Estrogen receptor-alpha as a predictive biomarker in endometrioid endometrial cancer"],"prefix":"10.1016","volume":"141","author":[{"given":"Floor J.","family":"Backes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher J.","family":"Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul J.","family":"Goodfellow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erinn M.","family":"Hade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Garima","family":"Agarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Mutch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David E.","family":"Cohn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian A.","family":"Suarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2016.03.006_bb0005","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3322\/caac.20138","article-title":"Cancer statistics, 2012","volume":"62","author":"Siegel","year":"2012","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.ygyno.2016.03.006_bb0010","series-title":"Cancer Facts & Figures 2012","author":"American Cancer Society","year":"2012"},{"key":"10.1016\/j.ygyno.2016.03.006_bb0015","doi-asserted-by":"crossref","first-page":"2716","DOI":"10.1200\/JCO.2005.06.178","article-title":"Population-based validation of the prognostic model ADJUVANT! For early breast cancer","volume":"23","author":"Olivotto","year":"2005","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2016.03.006_bb0020","doi-asserted-by":"crossref","first-page":"3726","DOI":"10.1200\/JCO.2005.04.7985","article-title":"Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer","volume":"24","author":"Paik","year":"2006","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2016.03.006_bb0025","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1038\/415530a","article-title":"Gene expression profiling predicts clinical outcome of breast cancer","volume":"415","author":"van 't Veer","year":"2002","journal-title":"Nature."},{"key":"10.1016\/j.ygyno.2016.03.006_bb0030","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S1470-2045(09)70314-6","article-title":"Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial","volume":"11","author":"Albain","year":"2010","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ygyno.2016.03.006_bb0035","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.ygyno.2008.10.032","article-title":"Expression of estrogen receptor-alpha and -beta and progesterone receptor-A and -B in a large cohort of patients with endometrioid endometrial cancer","volume":"112","author":"Jongen","year":"2009","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2016.03.006_bb0040","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.ajog.2008.04.043","article-title":"GATA3 expression in estrogen receptor alpha-negative endometrial carcinomas identifies aggressive tumors with high proliferation and poor patient survival","volume":"199","author":"Engelsen","year":"2008","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2016.03.006_bb0045","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1158\/1078-0432.CCR-12-3039","article-title":"Lack of estrogen receptor-alpha is associated with epithelial-mesenchymal transition and PI3K alterations in endometrial carcinoma","volume":"19","author":"Wik","year":"2013","journal-title":"Clin. Cancer Res. Off J. Am. Assoc. Cancer Res."},{"key":"10.1016\/j.ygyno.2016.03.006_bb0050","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.ygyno.2009.05.026","article-title":"Prospective evaluation of DNA mismatch repair protein expression in primary endometrial cancer","volume":"114","author":"Backes","year":"2009","journal-title":"Gynecol. Oncol."},{"issue":"Suppl. 2","key":"10.1016\/j.ygyno.2016.03.006_bb0055","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1038\/modpathol.2008.34","article-title":"Current issues in ER and HER2 testing by IHC in breast cancer","volume":"21","author":"Gown","year":"2008","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.ygyno.2016.03.006_bb0060","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.1200\/JCO.2009.25.6529","article-title":"American Society of Clinical Oncology\/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer","volume":"28","author":"Hammond","year":"2010","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2016.03.006_bb0065","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1002\/cncr.29046","article-title":"Polymerase varepsilon (POLE) mutations in endometrial cancer: clinical outcomes and implications for Lynch syndrome testing","volume":"121","author":"Billingsley","year":"2015","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2016.03.006_bb0070","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1200\/JCO.2006.08.2107","article-title":"Microsatellite instability and epigenetic inactivation of MLH1 and outcome of patients with endometrial carcinomas of the endometrioid type","volume":"25","author":"Zighelboim","year":"2007","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2016.03.006_bb0075","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1002\/humu.22463","article-title":"High frequency strand slippage mutations in CTCF in MSI-positive endometrial cancers","volume":"35","author":"Zighelboim","year":"2014","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.ygyno.2016.03.006_bb0080","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djv249","article-title":"Patterns of CTCF and ZFHX3 mutation and associated outcomes in endometrial cancer","volume":"107","author":"Walker","year":"2015","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.ygyno.2016.03.006_bb0085","unstructured":"The Cancer Genome Atlas (TCGA) Pilot Project. 2012."},{"key":"10.1016\/j.ygyno.2016.03.006_bb0090","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","article-title":"Regression models and life tables","volume":"B34","author":"Cox","year":"1972","journal-title":"J. R. Stat. Soc."},{"key":"10.1016\/j.ygyno.2016.03.006_bb0095","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Nonparametric estimation from incomplete observations","volume":"53","author":"Kaplan","year":"1958","journal-title":"J. Am. Stat. Assoc."},{"key":"10.1016\/j.ygyno.2016.03.006_bb0100","first-page":"185","article-title":"Asymptotically efficient rank invariant procedures","volume":"A135","author":"Peto","year":"1972","journal-title":"J. R. Stat. Soc."},{"key":"10.1016\/j.ygyno.2016.03.006_bb0105","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1093\/aje\/kwh090","article-title":"A modified poisson regression approach to prospective studies with binary data","volume":"159","author":"Zou","year":"2004","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.ygyno.2016.03.006_bb0110","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1038\/ng.2823","article-title":"Activating ESR1 mutations in hormone-resistant metastatic breast cancer","volume":"45","author":"Robinson","year":"2013","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ygyno.2016.03.006_bb0115","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1038\/ng.2822","article-title":"ESR1 ligand-binding domain mutations in hormone-resistant breast cancer","volume":"45","author":"Toy","year":"2013","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ygyno.2016.03.006_bb0120","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1093\/jnci\/djn397","article-title":"Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial","volume":"100","author":"Benedetti Panici","year":"2008","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.ygyno.2016.03.006_bb0125","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0140-6736(08)61766-3","article-title":"Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study","volume":"373","author":"Kitchener","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.ygyno.2016.03.006_bb0130","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.ygyno.2012.06.035","article-title":"Prospective assessment of survival, morbidity, and cost associated with lymphadenectomy in low-risk endometrial cancer","volume":"127","author":"Dowdy","year":"2012","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2016.03.006_bb0135","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1097\/01.AOG.0000245444.14015.00","article-title":"A prospective blinded evaluation of the accuracy of frozen section for the surgical management of endometrial cancer","volume":"108","author":"Case","year":"2006","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2016.03.006_bb0140","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.jamcollsurg.2004.05.258","article-title":"Frozen section analyses as predictors of lymphatic spread in patients with early-stage uterine cancer","volume":"199","author":"Frumovitz","year":"2004","journal-title":"J. Am. Coll. Surg."},{"key":"10.1016\/j.ygyno.2016.03.006_bb0145","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0021912","article-title":"The role of frozen section in surgical staging of low risk endometrial cancer","volume":"6","author":"Kumar","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.ygyno.2016.03.006_bb0150","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1111\/IGC.0b013e3181bff64b","article-title":"Frozen section underestimates the need for surgical staging in endometrial cancer patients","volume":"19","author":"Papadia","year":"2009","journal-title":"Int. J. Gynecol. Cancer Off. J. Int. Gynecol. Cancer Soc."},{"key":"10.1016\/j.ygyno.2016.03.006_bb0155","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ygyno.2012.04.009","article-title":"Detection of sentinel lymph nodes in patients with endometrial cancer undergoing robotic-assisted staging: a comparison of colorimetric and fluorescence imaging","volume":"126","author":"Holloway","year":"2012","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2016.03.006_bb0160","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1158\/1055-9965.EPI-08-0713","article-title":"Sampling strategies for tissue microarrays to evaluate biomarkers in ovarian cancer","volume":"18","author":"Permuth-Wey","year":"2009","journal-title":"Cancer Epidemiol, Biomark. Prev. Publ. Am. Assoc. Cancer Res. Cosponsored Am. Soc. Prev. Oncol."},{"key":"10.1016\/j.ygyno.2016.03.006_bb0165","first-page":"3313","article-title":"Validation of 2-mm tissue microarray technology in gastric cancer. Agreement of 2-mm TMAs and full sections for Glut-1 and Hif-1 alpha","volume":"34","author":"Berlth","year":"2014","journal-title":"Anticancer Res."},{"key":"10.1016\/j.ygyno.2016.03.006_bb0170","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.tranon.2014.06.001","article-title":"Tumor heterogeneity at protein level as an independent prognostic factor in endometrial cancer","volume":"7","author":"Supernat","year":"2014","journal-title":"Transl. Oncol."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825816300622?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825816300622?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,14]],"date-time":"2024-06-14T22:40:00Z","timestamp":1718404800000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825816300622"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,5]]}},"alternative-id":["S0090825816300622"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2016.03.006","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2016,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Estrogen receptor-alpha as a predictive biomarker in endometrioid endometrial cancer","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2016.03.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}